October 23, 2024
Therapeutic drug monitoring (TDM) — the practice of using laboratory testing to measure blood levels of drugs — has garnered growing interest among rheumatologists in managing […]
October 22, 2024
TOPLINE: Guselkumab administered every 8 weeks (Q8W) leads to durable improvement in disease activity along with improvements in both skin and joint symptoms over 2 years […]
October 16, 2024
TOPLINE: Patients with systemic sclerosis (SSc) who exhibit abnormal small bowel transit are more likely to be men, experience more severe cardiac involvement, have a higher […]
October 15, 2024
The US Food and Drug Administration (FDA) has approved ustekinumab-srlf (Imuldosa) as a biosimilar to ustekinumab (Stelara) for the treatment of multiple inflammatory conditions. This is […]
October 15, 2024
TOPLINE: Genetic predisposition to gout, unfavorable lifestyle habits, and poor metabolic health are associated with an increased risk for cardiovascular disease (CVD); however, adherence to a […]
October 15, 2024
TOPLINE: Tumor necrosis factor (TNF) inhibitors are associated with a reduced risk for recurrent cardiovascular events in patients with radiographic axial spondyloarthritis (axSpA) and a history […]
October 15, 2024
TOPLINE: Both low and high levels of maternal 25-hydroxy [25(OH)] vitamin D are linked to an increased risk for adverse pregnancy outcomes in women with systemic […]
October 11, 2024
TOPLINE: A study has found that less than half of US veterans on chronic immunosuppressive medications, and a much lower percentage of those younger than 50 […]
October 9, 2024
TOPLINE: Long-term antibiotic usage is associated with an increased risk for rheumatoid arthritis (RA). METHODOLOGY: Researchers conducted a population-based retrospective cohort study using data from the […]